Cited by 140Treatment of Major DepressionMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Quality of life in major depressive disorder before/after multiple steps of treatment and one‐year follow‐up

Open access
IsHak, W. W., Mirocha, J., James, D., Tobia, G., Vilhauer, J., Fakhry, H., Pi, S., Hanson, E. +3 more·2015·Acta Psychiatrica Scandinavica

Abstract

Objective: This study examines the impact of major depressive disorder (MDD) and its treatment on quality of life (QOL). Method: From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial, we analyzed complete data of 2280 adult MDD out‐patients at entry/exit of each level of antidepressant treatments and after 12 months of entry to follow‐up. QOL was measured using the QOL Enjoyment and Satisfaction Questionnaire (Q‐LES‐Q). The proportions of patients scoring ‘within‐normal’ QOL (within 10% of Q‐LES‐Q community norms) and those with ‘severely impaired’ QOL (>2 SD below Q‐LES‐Q community norms) were analyzed. Results: Before treatment, no more than 3% of MDD patients experienced ‘within‐normal’ QOL. Following treatment, statistically significant improvements were detected; however, the proportion of patients achieving ‘within‐normal’ QOL did not exceed 30%, with >50% of patients experiencing ‘severely impaired’ QOL. Although remitted patients had greater improvements compared with non‐remitters, 32–60% continued to experience reduced QOL. 12‐month follow‐up data revealed that the proportion of patients experiencing ‘within‐normal’ QOL show a statistically significant decrease in non‐remitters. Conclusion: Symptom‐focused treatments of MDD may leave a misleading impression that patients have recovered when, in fact, they may be experiencing ongoing QOL deficits. These findings point to the need for investigating specific interventions to ameliorate QOL in MDD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acps.12301

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An unintended consequence of a TRD framework that is hierarchical is encouraging multiple unproven treatment strategies, with polypharmacy and the possibility of associated safety and tolerability concerns.

    “Furthermore, an unintended consequence of a TRD framework that is hierarchical is encouraging mul­ tiple unproven treatment strategies, with poly­ pharmacy and the possibility of associated safety and tolerability concerns 70,75 .”

    From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [75]

    The Methods (Treatments Administered; page not supplied) describe successive STAR*D treatment levels with switching and augmentation, and the Discussion (Limitations and Strengths; page not supplied) notes that medication adverse effects could negatively affect quality of life. The paper does not say that a hierarchical TRD framework encourages unproven strategies or polypharmacy, or link that framework to safety and tolerability concerns. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • The predictive utility of quality of life as a critical outcome measure when defining TRD is underscored by the observation that persons remitting with antidepressants who continue to report decreased quality of life are at greater risk of relapse and recurrence.

    “The predictive utility of quality of life as a critical outcome measure when defining TRD is underscored by the observation that persons remitting with antidepressants who continue to report decreased quality of life are at greater risk of relapse and recurrence 74,75 .”

    From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [75]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Existing TRD definitions fail to take into consideration the social, economic, anamnestic and interpersonal factors which, alone or in combinations, are known to moderate antidepressant response.

    “Further drawbacks of existing TRD defi­ nitions are that they fail to take into consid­ eration the social, economic, anamnestic (e.g., adverse childhood experiences) and interpersonal factors which, alone or in combinations, are known to moderate antidepressant response 1,44,47,71,75-­ 81 .”

    From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [75]

    The Introduction (page unavailable) mentions social and economic factors only as correlates of poorer quality of life, not as moderators of antidepressant response. The Treatments Administered section (page unavailable) describes treatment steps but does not assess TRD definitions. Searches for childhood adversity, interpersonal factors, and response moderators found no passage supporting the attributed point. (LLM, conf=0.74)

    Experimental — accuracy not yet measured
  • Each relapse/recurrence is associated with an increased risk of future recurrence, as well as reduced quality-of-life and functioning.

    “Each relapse/recurrence is associated with an increased risk of future recurrence, 11 as well as reduced quality-of-life 12 and functioning. 13”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
IsHak, W. W., Mirocha, J., James, D., Tobia, G., Vilhauer, J., Fakhry, H., Pi, S., Hanson, E., Nashawati, R., Peselow, E. D., & Cohen, R. M.
Affiliations
  • Cedars-Sinai Medical Center (US)
  • Cairo University (EG)
  • Loma Linda University (US)
  • University of Southern California (US)
  • Richmond University Medical Center (US)
  • Emory University (US)
Corresponding author
IsHak, W. W.
Venue
Acta Psychiatrica Scandinavica
Publisher
Wiley
Published
2014-06-23
Volume
131
Issue
1
Pages
51-60
ISSN
  • 0001-690X (ISSN-L)
  • 1600-0447
OpenAlex
W1988690727
Cited by
140
References
57
Citations by year
2026: 7 · 2025: 19 · 2024: 10 · 2023: 17 · 2022: 19 · 2021: 21 · 2020: 9 · 2019: 10 · 2018: 11 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 2
FWCI
3.88
Type
journal article
Language
en
Open access
Locations
  • Acta Psychiatrica Scandinavica (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (n01mh90003-26-0-0)
  • National Institute of Mental Health (N01 MH090003)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
major depressive disorder, quality of life, antidepressant treatment, STAR*D trial, Q-LES-Q, remission, treatment-resistant depression, long-term follow-up, symptomatic treatment
MeSH terms
Adolescent, Adult, Aged, Antidepressive Agents, Combined Modality Therapy, Major Depressive Disorder, Female, Follow-Up Studies, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Cognitive Behavioral Therapy, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review